Cholecalciferol and calcifediol for vitamin D supplementation.
Cholecalciferol and calcifediol for vitamin D supplementation.
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Ten years change in post-fracture care for hip fracture patients.
Ten years change in post-fracture care for hip fracture patients.
Analysis of bone impairment by 3D DXA hip measures in patients with primary hyperparathyroidism: a pilot study.
Analysis of bone impairment by 3D DXA hip measures in patients with primary hyperparathyroidism: a pilot study.
Targeting Macrophages: Friends or Foes in Disease? Front Pharmacol.
Targeting Macrophages: Friends or Foes in Disease? Front Pharmacol.
Relationship between 1,25-Dihydroxyvitamin D and Body Composition in Middle-Aged Sedentary Adults: The FIT-AGEING Study. Nutrients
Relationship between 1,25-Dihydroxyvitamin D and Body Composition in Middle-Aged Sedentary Adults: The FIT-AGEING Study. Nutrients
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
